Biomaterials and regenerative medicines developer Collagen Solutions updated the market on its order book and contracted development revenues on Tuesday, following the signing of a "significant" new contract.
The AIM-traded firm said it recently finalised a number of contracts, including the Novabone supply agreement on 7 July, and a new supply agreement with an
